ECbiotech Taiwan

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

1 in Phase 3

Quick facts

Phase 3 pipeline

Extract of Agaricus blazei Murill · Oncology; Immunology
Agaricus blazei Murill extract enhances immune function through polysaccharide and beta-glucan components that activate macrophages, natural killer cells, and other innate immune cells.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

ECbiotech Taiwan portfolio CI brief
ECbiotech Taiwan pipeline updates RSS

Frequently asked questions about ECbiotech Taiwan

What is ECbiotech Taiwan's pipeline?

ECbiotech Taiwan has 1 drugs in Phase 3, 0 in Phase 2, 0 in Phase 1. Late-stage candidates include Extract of Agaricus blazei Murill.

Sector hub: All tracked pharma companies